Clearside Biomedical, Inc.
CLSDQ
$0.95
$0.1215.14%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.00M | -27.71M | -30.81M | -34.35M | -31.88M |
| Total Depreciation and Amortization | 332.00K | 323.00K | 283.00K | 226.00K | 167.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.29M | 9.63M | 9.33M | 11.11M | 12.78M |
| Change in Net Operating Assets | -1.92M | -3.97M | -1.48M | -1.68M | -20.00K |
| Cash from Operations | -21.29M | -21.73M | -22.68M | -24.70M | -18.95M |
| Capital Expenditure | -453.00K | -506.00K | -929.00K | -977.00K | -653.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.75M | 11.35M | 339.00K | 339.00K | -9.41M |
| Cash from Investing | 9.30M | 10.85M | -590.00K | -638.00K | -10.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.51M | 3.52M | 2.54M | 16.44M | 15.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.40M | -1.50M | -1.00M | -- | -1.00M |
| Cash from Financing | 4.91M | 2.02M | 1.54M | 16.44M | 14.10M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.09M | -8.86M | -21.73M | -8.90M | -14.91M |